Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-induced immune thrombotic thrombocytopenia
Adam J. Kanack, Anand Padmanabhan
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101381-101381
Open Access | Times Cited: 20

Showing 20 citing articles:

Neurological Adverse Reactions to SARS-CoV-2 Vaccines
Josef Finsterer
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 2, pp. 222-239
Open Access | Times Cited: 29
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Thanh N. Nguyen, Muhammad M. Qureshi, Piers Klein, et al.
Journal of Stroke (2022) Vol. 24, Iss. 2, pp. 256-265
Open Access | Times Cited: 38
Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies
Armand N. Yazdani, Nathaniel DeMarco, Parth R. Patel, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 662-662
Open Access | Times Cited: 12
D-dimer in systemic circulation and COVID-19 outcome
Likhita Nandigam, Maria Antonia Rico Mesa, Ryan Geffin, et al.
Elsevier eBooks (2025), pp. 369-385
Closed Access
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2
Muralimanohara S. T. Murala, Vivek Gairola, Ekramy E. Sayedahmed, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 406-406
Open Access
Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
M Mahmoudian Shoushtari, Farzin Roohvand, Mostafa Salehi‐Vaziri, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 12
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Thanh N. Nguyen, Muhammad M. Qureshi, Piers Klein, et al.
Journal of Stroke (2024) Vol. 26, Iss. 1, pp. 129-129
Open Access | Times Cited: 2
Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy
Justin C. Konje, Mariam Al Beloushi, Badreldeen Ahmed
Viruses (2023) Vol. 15, Iss. 3, pp. 621-621
Open Access | Times Cited: 6
Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S
Frank Struyf, Karin Hardt, Rian Van Rampelbergh, et al.
Vaccine (2023) Vol. 41, Iss. 37, pp. 5351-5359
Open Access | Times Cited: 5
No Red Flags for Risk of Retinal Vascular Occlusion After mRNA COVID-19 Vaccination
Lee M. Jampol, Maureen G. Maguire
JAMA Ophthalmology (2023) Vol. 141, Iss. 5, pp. 447-447
Open Access | Times Cited: 4
Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management
Meng Ge, Danyal Ladha, Jennifer Lymer, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 2, pp. 102357-102357
Open Access | Times Cited: 1
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study
Jérémie Botton, Marion Bertrand, Marie-Joëlle Jabagi, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126252-126252
Open Access | Times Cited: 1
COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes
Gewil Daniella Olipas Allas, Joekeem D. Arizala, Rafael Vincent M. Manalo
Hematology Reports (2022) Vol. 14, Iss. 4, pp. 358-372
Open Access | Times Cited: 6
Hematologic abnormalities after COVID-19 vaccination: A large Korean population-based cohort study
Hye Sook Choi, Min Ho Kim, Myeong Geun Choi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 Vaccinated Individuals
José Manuel Ornelas-Aguirre, Alejandro V. Gómez-Alcalá, Diego H. Ramírez Leyva
Archives of Medical Research (2022) Vol. 53, Iss. 4, pp. 341-351
Closed Access | Times Cited: 3
Perioperative cardiovascular risk and preventions of patients with post-COVID-19 condition
St T. Lai, Su Min
Heliyon (2024) Vol. 10, Iss. 20, pp. e39345-e39345
Open Access
Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination
Jimin Hwang, Young Joo Han, Dong Keon Yon, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 114-121
Open Access | Times Cited: 3
Editorial: Case reports in thrombosis: 2022
Luca Spiezia
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access
Learning hematology while surfing the waves of the COVID-19 pandemic
Prantar Chakrabarti
Journal of Hematology and Allied Sciences (2022) Vol. 1, pp. 89-92
Closed Access
COVID-19 vaccine (Ad26.COV2.S), an unlikely culprit of portal vein thrombosis in a middle-aged man
Dariusz Uczkowski, Arunabh Sekhri
Thrombosis Update (2022) Vol. 8, pp. 100119-100119
Open Access
Page 1

Scroll to top